Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~1. Aged 18-90 years~2. PaO2/FiO2 (PFI) below 200 mmHg (26.7 kPa)~3. Suspected or verified SARS-CoV-2 infection~4. At least two risk factors for increased morbidity/mortality~   * Age above 50 years~  * Hypertension~  * Cardiovascular disease~  * Diabetes or pre-diabetes~  * Active or cured cancer~  * Asthma/COPD~  * Smoking~  * D-Dimer \> 1.0 mg/L~  * Auto-immune disease~5. Documented informed consent according to ICH-GCP and national regulations~Exclusion Criteria:~1. ARDS/pneumonia caused by other viral infections (positive for other virus)~2. ARDS/pneumonia caused by other non-viral infections or trauma~3. Known pregnancy or positive pregnancy test in women of childbearing age~4. Patients with previous lung fibrosis more than 10%~5. CT- or Spirometry-verified severe COPD with Emphysema~6. Contraindication for HBO according to local guidelines~7. Not likely to need ICU admission \< 7 days of screening (Subjective criteria that may exclude any patients that fulfil the other inclusion criteria but where the treating physician suspect a spontaneous recovery)~8. Mental inability, reluctance or language difficulties that result in difficulty understanding the meaning of study participation~9. Prisoner (Exclusion criteria according to IRB at UCSD)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Hyperbaric oxygen (Type: EXPERIMENTAL): Hyperbaric oxygen 1,6-2.4 Bar for 30-60 minutes (compression/decompression time, according to local routines) in addition to best practice
- Control (Type: NO_INTERVENTION): Best practice

Based on this trial design, predict the completion outcome and termination type (if applicable).